Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AMG 224 / Amgen
NCT02539667: A Phase 1 First in Human Study of AMG 224 in Subjects With Relapsed or Refractory Multiple Myeloma	Not yet recruiting	1	50	NA	AMG 224	Amgen	Multiple Myeloma	05/17	11/18